European Archives - Page 55 of 1205 - European Medical Journal

Longer Duration of Obesity Linked to Poorer Survival in Children with Leukaemia

Children with ALL who are overweight or obese at multiple points during treatment have worse survival rates and higher relapse risk, according to a cohort study of 794 patients.

Healthcare-Associated Infections Affect Over 50% of Care Home Residents

More than half of residents in European care homes experience at least one healthcare-associated infection each year, according to a major ECDC-led study.

Weight Loss Surgery Linked to Psoriasis Symptom Relief

Following surgery, 97.2% of patients experienced a reduction in psoriasis severity to mild levels or complete resolution.

New Evidence Supports Finerenone Use in Heart Failure, Regardless of Frailty

Finerenone benefits heart failure patients with preserved ejection fraction, regardless of frailty, supporting its wider clinical use.

Evaluating ChatGPT’s Role in Urological Education

Students using ChatGPT alone scored lower than those attending lectures suggesting that AI tools may not sufficiently support complex learning.

Global Study Reveals Wide Gaps in Paediatric Bronchiectasis Care

New global registry study reveals stark regional differences in diagnosis, treatment, and care quality for children with bronchiectasis.

Tracking A&E Demand in Sickle Cell Disease

A new cohort study analysing over 100,000 A&E visits in North Carolina has redefined what constitutes high emergency care use among people with sickle cell disease.

Cannabis Use Linked to Increased Cardiovascular Health Risks

THC, the main psychoactive compound, can stimulate the sympathetic nervous system, potentially causing tachycardia, vasoconstriction, and increased oxygen demand.

Lifestyle Changes Improve Liver Health in Patients with HIV

The findings highlight the potential for behavioural strategies, such as dietitian-led interventions, to play a key role in managing liver health.

FDA investigates trials sending US cells to foreign labs

The FDA has launched an immediate review of clinical trials involving the export of American patients’ living cells to China and other “hostile countries”.